SEC FORM 4
$184,910.11
Skye Bioscience, Inc. (SKYE)
Sale of 114,851 shares at $1.61 per share.
Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 24, 2026
Source: SEC Form 4 · 0001231919-26-001224 · filed 2026-09-24 · View filing →